21，Michaels AS，Chandrasekaran SK，Shaw JW．Drug permeation through human skin:theory and in vitro experimental measuremant．AIChE J，1975，21∶985-996．
32，Sebel PS， Harrett CW， Kirk CJC， et al． Transdermal absorption of fentanyl and sufentanyl in man．Eur J Clin Pharmacol，1987，32∶529-531．
43，Guorlay GK， Kowalski SR， Plumme JL， et al． Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain．Anesth Analg，1988，67∶329-337．
54，Thompson JP， Bower S， Liddle AM， et al． Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients．Br J Anaesth，1998，81∶152-154．
65，Collins JJ，Dunkel IJ，Gupta SK，et al．Transdermal fentanyl in children with cancer pain，feasibility，tolerability，and pharmacokinetics correlates．J Pediatr，1999，134∶319-323．
76，Portenoy RK，Southam MA，Gupta SK，et al．Transdermal fentanyl for cancer pain．Repeated dose pharmacokinetics．Anesthesiology，1993，78∶36-43．
87，Varvel JR，Shafer SL，Hwang SS，et al．Absorption characteristics of transdermally administered fentanyl．Anesthesiology，1989，70∶928-934．
98，Donner B，Zenz M．Transdemal fentanyl:a new step on the therapeutic ladder．Anticancer-Drugs，1995，6（Suppl 3）∶39-43．
109，Data on file，Janssen Pharmaceutical Limited．Zech，1992．N87258．
